Skip to main content
. 2017 Feb 23;139(12):4366–4375. doi: 10.1021/jacs.6b11851

Scheme 8. Crossover Studies.

Scheme 8

(i) (+)-BTM (20 mol %), iPr2NH (1.4 equiv), 25a (0.5 equiv), 31 (0.5 equiv), d3-MeCN/d6-DMSO (9:1), 253 K, 4 h; (ii) (+)-BTM (20 mol %), HOBt (20 mol %), iPr2NH (1.4 equiv), 26b (0.5 equiv), 33 (0.5 equiv), MeCN, 253 K.